Status:
COMPLETED
Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Nonmalignant Neoplasm
Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
RATIONALE: Chemoprevention is the use of certain substances to keep cancer from forming, growing, or coming back. Eating a diet high in lycopene, a substance found in tomatoes and tomato products, may...
Detailed Description
OBJECTIVES: * Assess the ability of prostatic tissue to accumulate doses of lycopene in patients with prostate cancer or benign prostate hyperplasia. * Determine whether the steady state level of DNA...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of 1 of the following:
- Prostate cancer
- Benign prostate hyperplasia
- High blood levels of prostate-specific antigen
- Enlarged prostate
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2011
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00416390
End Date
March 1 2011
Last Update
September 20 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.